Cargando…

Clinical Genetics in Interstitial Lung Disease

Interstitial lung disease (ILD) comprises a heterogeneous group of diffuse parenchymal lung processes with overlapping clinical, radiographic, and histopathologic features. Among the most common and deadly ILDs are idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis (CHP). A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newton, Chad A., Molyneaux, Philip L., Oldham, Justin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932165/ https://www.ncbi.nlm.nih.gov/pubmed/29755982 http://dx.doi.org/10.3389/fmed.2018.00116

Ejemplares similares

Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response
por: Bowman, Willis S., et al.
Publicado: (2021)

Reply to Noboa-Sevilla et al.
por: Vu Pugashetti, Janelle, et al.
Publicado: (2022)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Interstitial Lung Abnormalities and Aging Biomarkers: A Mediation
por: Oldham, Justin M.
Publicado: (2021)

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
por: Case, Amy Hajari
Publicado: (2022)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

Role of the Microbiome in Interstitial Lung Diseases
por: Chioma, Ozioma S., et al.
Publicado: (2021)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001–2017
por: Salciccioli, Justin D., et al.
Publicado: (2022)

Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
por: Bosello, Silvia Laura, et al.
Publicado: (2021)

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Novel diagnostic techniques in interstitial lung disease
por: Glenn, Laura M., et al.
Publicado: (2023)

Variability in Global Prevalence of Interstitial Lung Disease
por: Kaul, Bhavika, et al.
Publicado: (2021)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Editorial: Interstitial Lung Disease Around the World
por: Wijsenbeek, Marlies, et al.
Publicado: (2022)

The prognostic value of gastroesophageal reflux disorder in interstitial lung disease related hospitalizations
por: Alqalyoobi, Shehabaldin, et al.
Publicado: (2023)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022)

Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
por: Ceribelli, Angela, et al.
Publicado: (2023)

Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard
por: Lee, Cathryn T., et al.
Publicado: (2022)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Metformin-Induced Eosinophilic Interstitial Lung Disease
por: Alyami, Sami M, et al.
Publicado: (2023)

Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
por: Boustani, Karim, et al.
Publicado: (2022)

Diagnosing interstitial lung disease by multidisciplinary discussion: A review
por: Glenn, Laura M., et al.
Publicado: (2022)

Genetic and environmental factors in interstitial lung diseases: current and future perspectives on early diagnosis of high-risk cohorts
por: Stanel, Stefan Cristian, et al.
Publicado: (2023)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018)

A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis
por: Li, Yimin, et al.
Publicado: (2021)

Recent Advances in the Treatment of Interstitial Lung Diseases
por: Bang, Aneesh A, et al.
Publicado: (2023)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
por: Laria, Antonella, et al.
Publicado: (2022)

Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion
por: Liossis, Stamatis-Nick C., et al.
Publicado: (2022)

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
por: Kamenova, Antoniya, et al.
Publicado: (2023)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
por: Mirsaeidi, Mehdi, et al.
Publicado: (2019)

Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
por: Korsten, Peter, et al.
Publicado: (2021)

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
por: Sambataro, Gianluca, et al.
Publicado: (2022)

The genetics of interstitial lung diseases
por: Borie, Raphael, et al.
Publicado: (2019)

Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
por: Hervier, Baptiste, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vcu0g5i0lf34em8b6upr40bnpi